Tevogen Bio Inc.
TVGN | NASDAQ
$5.94
+$0.04 (+0.68%)
Nov 2, 2026, 11:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
Net Income | -26.28M | -13.73M | -60.48M | -22.04M | -15.6M |
Depreciation & Amortization | 509.2K | 403.58K | 378.36K | 230.82K | 9.38K |
Stock-Based Compensation | 16.22M | 40.76M | n/a | 4.58M | 582.41K |
Other Working Capital | -760.38K | -1.69M | -554.06K | -96.92K | -156.34K |
Other Non-Cash Items | -60.7K | -39.43M | 51.64M | 8.67M | 10.98M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.72M | -5.49K | 293.21K | -96.92K | -1.25M |
Operating Cash Flow | -12.33M | -12M | -8.17M | -8.66M | -5.27M |
Capital Expenditures | -64.44K | n/a | -133K | -479.04K | -109.73K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -64.44K | n/a | -133K | -479.04K | -109.73K |
Debt Repayment | 3.4M | 1M | 4M | 7.5M | 12.5M |
Common Stock Repurchased | n/a | n/a | -342.98M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.4M | 229.33K | 342.86M | n/a | n/a |
Financial Cash Flow | 11.66M | 12.23M | 3.87M | 7.5M | 12.5M |
Net Cash Flow | -730.62K | 230.6K | -4.43M | -1.63M | 7.12M |
Free Cash Flow | -12.39M | -12M | -8.3M | -9.13M | -5.38M |
Adj. Free Cash Flow | -28.62M | -52.76M | -8.3M | -13.71M | -5.97M |
Maintenance CapEx | -64.44K | n/a | -133K | -230.82K | -9.38K |
Growth CapEx | n/a | n/a | n/a | -248.22K | -100.35K |
Owner Earnings | -12.39M | -12M | -8.3M | -8.89M | -5.28M |
Add to Watchlist
Select watchlists to add or remove TVGN